James Chan

ORCID: 0000-0001-7173-5029
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyotrophic Lateral Sclerosis Research
  • Autism Spectrum Disorder Research
  • Parkinson's Disease Mechanisms and Treatments
  • Long-Term Effects of COVID-19
  • Family and Disability Support Research
  • Neurogenetic and Muscular Disorders Research
  • Child Nutrition and Feeding Issues
  • Cerebral Palsy and Movement Disorders
  • Attention Deficit Hyperactivity Disorder
  • Infant Development and Preterm Care
  • COVID-19 Clinical Research Studies
  • COVID-19 and Mental Health
  • Genetics and Neurodevelopmental Disorders
  • Dysphagia Assessment and Management
  • Dental Health and Care Utilization
  • Biochemical Acid Research Studies
  • COVID-19 Impact on Reproduction
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Pediatric health and respiratory diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Palliative Care and End-of-Life Issues
  • Intensive Care Unit Cognitive Disorders
  • Neurological diseases and metabolism
  • Acute Myocardial Infarction Research
  • Respiratory Support and Mechanisms

Massachusetts General Hospital
2015-2024

Amyotrophic Lateral Sclerosis Association
2024

Harvard University
2014-2023

Clinical Research Institute
2023

Northwestern University
2023

Public Health Ontario
2023

University of Toronto
2023

University of California, San Diego
2023

National Institute of Neurological Disorders and Stroke
2023

Toronto Western Hospital
2023

Abstract An orally administered, fixed‐dose coformulation of sodium phenylbutyrate‐taurursodiol (PB‐TURSO) significantly slowed functional decline in a randomized, placebo‐controlled, phase 2 trial ALS (CENTAUR). Herein we report results long‐term survival analysis participants CENTAUR. In CENTAUR, adults with were randomized 2:1 to PB‐TURSO or placebo. Participants completing the 6‐month (24‐week) eligible receive open‐label extension. all‐cause mortality (35‐month maximum follow‐up...

10.1002/mus.27091 article EN cc-by-nc Muscle & Nerve 2020-10-16
Rachel S. Gross Tanayott Thaweethai Lawrence C. Kleinman Jessica Snowden Erika B. Rosenzweig and 95 more Joshua D. Milner Kelan G. Tantisira Kyung E. Rhee Terry L. Jernigan Patricia A. Kinser Amy L. Salisbury David Warburton Sindhu Mohandas John C. Wood Jane W. Newburger Dongngan T. Truong Valerie J. Flaherman Torri D. Metz Elizabeth W. Karlson Lori B. Chibnik Deepti Pant Aparna Krishnamoorthy Richard Gallagher Michelle F. Lamendola-Essel Denise Hasson Stuart D. Katz H. Shonna Yin Benard P. Dreyer Megan Carmilani Krista Coombs Megan Fitzgerald Nick Güthe Mady Hornig Rebecca Letts Aimee K. Peddie Brittany D. Taylor Andrea S. Foulkes Melissa S. Stockwell Venkataraman Balaraman Amanda Bogie Hülya Bükülmez Allen J. Dozor Daniel Eckrich Amy Elliott Danielle N. Evans Jonathan S. Farkas E. Vincent S. Faustino Laura Vega Sunanda Gaur Ashraf S. Harahsheh Uzma Hasan Daniel S. Hsia Gredia Huerta-Montañez Kathy D. Hummel Matt P. Kadish David C. Kaelber Sankaran Krishnan Jessica S. Kosut Jerry Larrabee Peter Paul Lim Ian C. Michelow Carlos R. Oliveira Hengameh H. Raissy Zaira Rosario-Pabón Judith L. Ross Alice I. Sato Michelle D. Stevenson Maria M. Talavera‐Barber Ronald J. Teufel Kathryn Weakley Emily Zimmerman Marie‐Abèle Bind James Chan Zoe Guan Richard E. Morse Harrison T. Reeder Natascha Akshoomoff Judy L. Aschner Rakesh Bhattacharjee Lesley Cottrell Kelly Cowan Viren D’Sa Alexander G. Fiks Maria Laura Gennaro Katherine Irby Manaswitha Khare Jeremy Landeo Guttierrez Russell J. McCulloh Shalu Narang Manette Ness- Cochinwala Sheila M. Nolan Paul Palumbo Julie Ryu Juan C. Salazar Rangaraj Selvarangan Cheryl R. Stein Alan Werzberger William T. Zempsky Robin L. Aupperle Fiona C. Baker

Most research to understand postacute sequelae of SARS-CoV-2 infection (PASC), or long COVID, has focused on adults, with less known about this complex condition in children. Research is needed characterize pediatric PASC enable studies underlying mechanisms that will guide future treatment.

10.1001/jama.2024.12747 article EN JAMA 2024-08-21

To examine rehabilitation interventions and resulting physical activity patterns of patients managed in acute stroke units to help inform development a randomized controlled trial very early rehabilitation.An open observational study patient therapist report interventions. A survey unit resources.Patients less than 14 days post-stroke from 5 metropolitan were observed over 2 consecutive weekdays at 10-minute intervals between 08.00 h 17.00 h. Physical activity, location person(s) present...

10.2340/16501977-0013 article EN Acta Dermato Venereologica 2007-01-01

Objective: A randomized pilot trial of gastrointestinal (GI) symptoms targeting probiotic for quality life in autism spectrum disorder (ASD). Methods: Thirteen children, 3-12 years age with ASD, anxiety, and GI symptoms, were into a crossover 8 weeks each on VISBIOME placebo separated by 3-week washout. contains eight species, mostly Lactobacillus Bifidobacterium. Primary outcome was the Pediatric Quality Life Inventory (PedsQL) module. Secondary outcomes included gut microbiota analysis,...

10.1089/cap.2018.0156 article EN Journal of Child and Adolescent Psychopharmacology 2019-09-03

To characterize [11 C]-PBR28 brain uptake using positron emission tomography (PET) in people with amyotrophic lateral sclerosis (ALS) and primary (PLS). We have previously shown increased the precentral gyrus a small group of ALS patients. Herein, we confirm our initial finding, study longitudinal changes, gray versus white matter distribution larger cohort patients PLS.Eighty-five participants including 53 ALS, 11 PLS, 21 healthy controls underwent integrated PET-magnetic resonance imaging....

10.1002/ana.25251 article EN Annals of Neurology 2018-05-09

Objective To characterize the gut microbiota in people with amyotrophic lateral sclerosis (ALS) relative to controls and test hypothesis that butyrate-producing bacteria are less abundant gastrointestinal tracts of ALS (PALS). Methods: We conducted a case–control study at Massachusetts General Hospital compare controls. Metagenomic shotgun sequencing was performed on DNA extracted from stool samples 66 (PALS), 61 healthy (HC), 12 neurodegenerative (NDC). Taxonomic metagenomic profiles were...

10.1080/21678421.2020.1828475 article EN cc-by Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2020-11-02

The amyotrophic lateral sclerosis (ALS) trial outcome measures are clinic based. Active and passive smartphone data can provide important longitudinal information about ALS progression outside the clinic.We used Beiwe, a research platform for smartphone-based digital phenotyping, to collect active (self-report ALSFRS-R surveys speech recordings) (phone sensors logs) from patients with approximately 24 weeks. In clinics, at baseline every 3 months, we collected vital capacity, ALSFRS-R,...

10.1002/acn3.770 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2019-04-03
Leora I. Horwitz Tanayott Thaweethai Shari B. Brosnahan Mine Cicek Megan Fitzgerald and 95 more Jason D. Goldman Rachel Hess S L Hodder Vanessa L. Jacoby Michael R. Jordan Jerry A. Krishnan Adeyinka O. Laiyemo Torri D. Metz Lauren Nichols Rachel E. Patzer Anisha Sekar Nora G. Singer Lauren E. Stiles Barbara S. Taylor Shifa Ahmed Heather A. Algren Khamal Anglin Lisa Aponte‐Soto Hassan Ashktorab Ingrid V. Bassett Brahmchetna Bedi Nahid Bhadelia Christian Bime Marie‐Abèle Bind Lora Black Andra L. Blomkalns Hassan Brim Mario Castro James Chan Alexander W. Charney Benjamin K. Chen Long‐Qing Chen Peter Chen David Chestek Lori B. Chibnik Dominic C. Chow Helen Y. Chu Rebecca G. Clifton Shelby Collins Maged M. Costantine Sushma K. Cribbs Steven G. Deeks John D. Dickinson Sarah E. Donohue Matthew S. Durstenfeld Ivette F. Emery Kristine M. Erlandson Julio C. Facelli Rachael Farah-Abraham Adam Finn Melinda S. Fischer Valerie J. Flaherman Judes Fleurimont Vivian Fonseca Emily J. Gallagher Jennifer C. Gander Maria Laura Gennaro Kelly S. Gibson Minjoung Go Steven N. Goodman Joey P. Granger Frank L. Greenway John W. Hafner Jenny E. Han Michelle Harkins Kristine Hauser James R. Heath Carla R. Hernandez On Ho Matthew Hoffman Susan E. Hoover Carol R. Horowitz Harvey Hsu Priscilla Y. Hsue Brenna L. Hughes Prasanna Jagannathan Judith A. James Janice John Sarah E. Jolley Suzanne E. Judd Joy J Juskowich Diane G. Kanjilal Elizabeth W. Karlson Stuart D. Katz J. Daniel Kelly Sara Warfield Kelly Arthur Y. Kim John P. Kirwan Kenneth S. Knox Andre Kumar Michelle F. Lamendola-Essel Margaret Lanca Joyce K. Lee-lannotti R. Craig Lefebvre Bruce D. Levy

Importance SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms other health effects after the acute phase of infection; termed post-acute sequelae (PASC), long COVID. The characteristics, prevalence, trajectory and mechanisms PASC are ill-defined. objectives Researching COVID to Enhance Recovery (RECOVER) Multi-site Observational Study Adults (RECOVER-Adult) to: (1) characterize prevalence; (2) symptoms, organ dysfunction, natural history, distinct phenotypes PASC; (3)...

10.1371/journal.pone.0286297 article EN cc-by PLoS ONE 2023-06-23

A recent meta-analysis documented a significant statistical association between mild traumatic brain injury (mTBI) and attention deficit hyperactivity disorder (ADHD) (Adeyemo et al., 2014), but the direction of this effect was unclear. In study, we hypothesized that ADHD would be an antecedent risk factor for mTBI. Participants were student athletes ages 12 to 25 who had sustained mTBI Controls similar age sex selected from studies youth with without ADHD. Subjects assessed symptoms ADHD,...

10.1097/nmd.0000000000000375 article EN The Journal of Nervous and Mental Disease 2015-10-13

Both working memory (WM; a brain system that provides temporary storage and manipulation of the information) attention-deficit/hyperactivity disorder (ADHD) have been associated with educational deficits. Since WM deficits are prevalent in children ADHD, main aim present study was to examine whether driven by or effect ADHD itself.Participants were referred youth (N = 276) without 241) ascertained from pediatric psychiatric sources. Assessment included measures psychiatric, psychosocial,...

10.1080/13803395.2015.1127896 article EN Journal of Clinical and Experimental Neuropsychology 2016-02-23

<h3>Importance</h3> The Extension for Community Health Outcomes (ECHO) model is a widely adopted technology-based training primary care physicians and practitioners (PCPs) to patients with complex conditions. Despite its popularity, our knowledge, direct effects of ECHO on clinical practice have not been tested in large-scale study. <h3>Objective</h3> To test the effectiveness as applied autism whether it resulted improved practice, self-efficacy regarding screening comorbidity management....

10.1001/jamapediatrics.2019.6306 article EN JAMA Pediatrics 2020-03-09

<para xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> A 16 Gb 4-state MLC NAND flash memory augments the sustained program throughput to 34 MB/s by fully exercising all available cells along a selected word line and using additional performance enhancement modes. The same chip operating as an 8 SLC device guarantees over 60 programming throughput. newly introduced All Bit Line (ABL) architecture has multiple advantages when higher is targeted it was...

10.1109/jssc.2008.2007152 article EN IEEE Journal of Solid-State Circuits 2009-01-01

Objective: Amyotrophic lateral sclerosis (ALS) has profound effects on people with ALS (PALS) and caregivers. There is a paucity of research detailing comparing PALS caregiver day-to-day perspectives ALS. Methods: A survey developed collaboratively by The Association panel experts in care was designed to broadly sample the experience caregivers respect physical emotional symptoms, efficacy treatment approaches, goals for future treatments. Specific symptoms assessed consisted fatigue, pain,...

10.1080/21678421.2020.1760889 article EN cc-by-nc-nd Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2020-05-12

Ibudilast (MN-166) is an inhibitor of macrophage migration inhibitory factor (MIF) and phosphodiesterases 3,4,10 11 (Gibson et al., 2006; Cho 2010). attenuates CNS microglial activation secretion pro-inflammatory cytokines (Fujimoto 1999; In vitro evidence suggests that ibudilast neuroprotective by suppressing neuronal cell death induced activation. People with ALS have increased measured [11C]PBR28-PET in the motor cortices. The primary objective to determine impact on reducing glial...

10.1016/j.nicl.2021.102672 article EN cc-by-nc-nd NeuroImage Clinical 2021-01-01
Rachel S. Gross Tanayott Thaweethai Erika B. Rosenzweig James Chan Lori B. Chibnik and 95 more Mine S. Cicek Amy Elliott Valerie J. Flaherman Andrea S. Foulkes Margot Gage Witvliet Richard Gallagher Maria Laura Gennaro Terry L. Jernigan Elizabeth W. Karlson Stuart D. Katz Patricia A. Kinser Lawrence C. Kleinman Michelle F. Lamendola-Essel Joshua D. Milner Sindhu Mohandas Praveen C. Mudumbi Jane W. Newburger Kyung E. Rhee Amy L. Salisbury Jessica Snowden Cheryl R. Stein Melissa S. Stockwell Kelan G. Tantisira Moriah E. Thomason Dongngan T. Truong David Warburton John C. Wood Shifa Ahmed Almary Akerlundh Akram N. Alshawabkeh Brett R. Anderson Judy L. Aschner Andrew M. Atz Robin L. Aupperle Fiona C. Baker Venkataraman Balaraman Dithi Banerjee Deanna M. Barch Arielle Baskin‐Sommers Sultana Bhuiyan Marie‐Abèle Bind Amanda Bogie Tamara T. Bradford Natalie C. Buchbinder Elliott Bueler Hülya Bükülmez B.J. Casey Linda Chang Maryanne Chrisant Duncan B. Clark Rebecca G. Clifton Katharine N. Clouser Lesley Cottrell Kelly Cowan Viren D’Sa Mirella Dapretto Soham Dasgupta Walter Dehority Audrey Dionne Kirsten B. Dummer Matthew D. Elias Shari Esquenazi‐Karonika Danielle N. Evans E. Vincent S. Faustino Alexander G. Fiks Daniel Forsha John J. Foxe Naomi P. Friedman Greta Fry Sunanda Gaur Dylan G. Gee Kevin M. Gray Stephanie S. Handler Ashraf S. Harahsheh Keren Hasbani Andrew C. Heath Camden L. Hebson Mary M. Heitzeg Christina M. Hester Sophia Hill Laura Hobart‐Porter Travis K.F. Hong Carol R. Horowitz Daniel S. Hsia Matthew J. Huentelman Kathy D. Hummel Katherine Irby Joanna Jacobus Vanessa L. Jacoby Pei‐Ni Jone David C. Kaelber Tyler J. Kasmarcak Matthew J. Kluko Jessica S. Kosut Angela R. Laird

Importance The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae SARS-CoV-2 [PASC] or “Long COVID”) in children young adults remain unknown. Studies must address the urgent need to define PASC, its mechanisms, potential treatment targets adults. Observations We describe protocol for Pediatric Observational Cohort Study NIH’s RE searching COV ID E nhance R ecovery (RECOVER) Initiative. RECOVER-Pediatrics is an observational meta-cohort study caregiver-child...

10.1371/journal.pone.0285635 article EN cc-by PLoS ONE 2024-05-07

ABSTRACT Introduction : Urate has been identified as a predictor of amyotrophic lateral sclerosis (ALS) survival in some but not all studies. Here we leverage the recent expansion Pooled Resource Open‐Access ALS Clinical Trials (PRO‐ACT) database to study association between urate levels and survival. Methods data 1,736 participants from PRO‐ACT were analyzed. Cox proportional hazards regression models used evaluate associations at trial entry Results After adjustment for potential...

10.1002/mus.25950 article EN Muscle & Nerve 2017-08-31

Neuroinflammation is increasingly tied to disease progression in amyotrophic lateral sclerosis (ALS). Participants the first-in-human trial of intra-spinal allogeneic stem cell therapy for ALS received immunosuppression, and one participant saw dramatic improvement across multiple outcome measures. The primary objective this study (NCT01884571) was assess rate clinical response same immunosuppressive regimen using basiliximab, tacrolimus, mycophenolate, prednisone people with ALS. A defined...

10.1080/21678421.2017.1421666 article EN Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2018-01-08

This prospective 12-week open-label trial evaluates the tolerability and efficacy of memantine hydrochloride for treatment core social cognitive deficits in adults with high-functioning autism spectrum disorder (ASD). Measures assessment therapeutic response included Social Responsiveness Scale-Adult Research Version (SRS-A), disorder-specific Clinical Global Impression scales, Behavior Rating Inventory Executive Functioning-Adult Self-Report, Diagnostic Analysis Nonverbal Accuracy Scale,...

10.1097/jcp.0000000000000499 article EN Journal of Clinical Psychopharmacology 2016-04-19

To test the safety, tolerability, and urate-elevating capability of urate precursor inosine taken orally or by feeding tube in people with amyotrophic lateral sclerosis (ALS).

10.1002/acn3.671 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2018-10-22

Higher urate levels are associated with improved ALS survival in retrospective studies, however whether raising confers a advantage is unknown. In the Safety of Urate Elevation Amyotrophic Lateral Sclerosis (SURE-ALS) trial, inosine raised serum and was safe well-tolerated. The SURE-ALS2 trial designed to assess longer term safety. Functional outcomes smartphone application were also explored.Participants randomized 2:1 (n = 14) or placebo 9) for 20 weeks, titrated 7-8 mg/dL. Primary safety...

10.1002/mus.27807 article EN cc-by-nc-nd Muscle & Nerve 2023-02-25
Coming Soon ...